L\u2019aspirine va \u00eatre test\u00e9e en tant que traitement potentiel du Covid-19 dans l\u2019un des plus grands essais cliniques du Royaume-Uni. Cette \u00e9tude, d\u00e9terminera si l\u2019aspirine peut r\u00e9duire le risque de caillots sanguins chez les personnes atteintes de la maladie.<\/p>\n
Les scientifiques \u00e0 l\u2019origine de l\u2019essai RECOVERY, qui examine une gamme de traitements potentiels du Covid-19, ont d\u00e9clar\u00e9 qu\u2019il y inclurait le m\u00e9dicament, couramment utilis\u00e9 comme fluidifiant sanguin.<\/p>\n
Les patients infect\u00e9s par le coronavirus courent un risque plus \u00e9lev\u00e9 de formation de caillots sanguins en raison de l\u2019hyperr\u00e9activit\u00e9 des plaquettes, les fragments de cellules qui aident \u00e0 arr\u00eater les saignements. Or l\u2019aspirine est un agent antiplaquettaire \u00e0 m\u00eame de pouvoir r\u00e9duire le risque de caillots, a soulign\u00e9 vendredi 6 novembre le site web de RECOVERY.<\/p>\n
\u00ab Il y a une raison claire de croire qu\u2019elle (l\u2019aspirine) pourrait \u00eatre b\u00e9n\u00e9fique, et elle est s\u00fbre, peu co\u00fbteuse et largement disponible \u00bb, a d\u00e9clar\u00e9 Peter Horby, un des responsables de l\u2019essai clinique.<\/p>\n
Au moins 2 000 patients devraient au hasard recevoir 150 mg d\u2019aspirine par jour en plus de leur traitement habituel. Les donn\u00e9es de ces patients seront compar\u00e9es \u00e0 celles d\u2019au moins 2 000 autres patients qui re\u00e7oivent le traitement standard pour le Covid-19, a indiqu\u00e9 le site web.<\/p>\n
Parmi les autres traitements test\u00e9s dans le cadre de l\u2019essai RECOVERY figurent l\u2019azithromycine, un antibiotique courant, et le cocktail d\u2019anticorps de Regeneron qui a \u00e9t\u00e9 utilis\u00e9 pour traiter le pr\u00e9sident am\u00e9ricain Donald Trump, lui-m\u00eame infect\u00e9 par le coronavirus.<\/p>\n
L\u2019essai RECOVERY a \u00e9t\u00e9 le premier \u00e0 montrer l\u2019efficacit\u00e9 du dexam\u00e9thasone, un cortico\u00efde bon march\u00e9 et largement disponible, dans le traitement des cas s\u00e9v\u00e8res de Covid-19.<\/p>\n
Avec Reuters<\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"L\u2019aspirine va \u00eatre test\u00e9e en tant que traitement potentiel du Covid-19 dans l\u2019un des plus grands essais cliniques du Royaume-Uni. Cette \u00e9tude, d\u00e9terminera si l\u2019aspirine peut r\u00e9duire le risque de caillots sanguins chez les personnes atteintes de la maladie. Les scientifiques \u00e0 l\u2019origine de l\u2019essai RECOVERY, qui examine une gamme de traitements potentiels du Covid-19, [...]","protected":false},"author":4,"featured_media":22672,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"content-type":"","jnews-multi-image_gallery":[],"jnews_single_post":{"subtitle":"","format":"standard","video":"","gallery":"","source_name":"","source_url":"","via_name":"","via_url":"","override":[{"single_blog_custom":"","sidebar":"","second_sidebar":"","share_position":"","share_float_style":"","post_date_format":"","post_date_format_custom":"","post_reading_time_wpm":"","zoom_button_out_step":"1","zoom_button_in_step":"1","number_popup_post":"1"}],"image_override":[{"single_post_thumbnail_size":"","single_post_gallery_size":""}],"trending_post_position":"","trending_post_label":"","sponsored_post_label":"","sponsored_post_name":"","sponsored_post_url":"","sponsored_post_logo":"","sponsored_post_desc":""},"jnews_primary_category":{"id":""},"jnews_override_bookmark_settings":[],"jnews_review":[],"enable_review":"","type":"","name":"","summary":"","brand":"","sku":"","good":[],"bad":[],"score_override":"","override_value":"","rating":[],"price":[],"jnews_post_split":[],"footnotes":""},"categories":[6,11],"tags":[4166,6040,6041],"class_list":["post-22671","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-world","category-health","tag-coronavirus","tag-essai-clinique","tag-laspirine"],"_links":{"self":[{"href":"https:\/\/www.africanchallenges.com\/index.php?rest_route=\/wp\/v2\/posts\/22671","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.africanchallenges.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.africanchallenges.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.africanchallenges.com\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.africanchallenges.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=22671"}],"version-history":[{"count":1,"href":"https:\/\/www.africanchallenges.com\/index.php?rest_route=\/wp\/v2\/posts\/22671\/revisions"}],"predecessor-version":[{"id":22673,"href":"https:\/\/www.africanchallenges.com\/index.php?rest_route=\/wp\/v2\/posts\/22671\/revisions\/22673"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.africanchallenges.com\/index.php?rest_route=\/wp\/v2\/media\/22672"}],"wp:attachment":[{"href":"https:\/\/www.africanchallenges.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=22671"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.africanchallenges.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=22671"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.africanchallenges.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=22671"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}